LCMS
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike

Method Modernization and Method Development (e-Book)

Guides | 2024 | Thermo Fisher ScientificInstrumentation
HPLC
Industries
Other
Manufacturer
Thermo Fisher Scientific

Summary

Significance of Topic


The demand for faster, more sensitive, and robust liquid chromatography methods continues to grow across pharmaceuticals, biotech, industrial QC, and research laboratories. Modernizing existing HPLC methods and adopting UHPLC platforms address stringent regulatory requirements, maximize laboratory throughput, reduce solvent consumption, and improve method reliability.

Objectives and Overview


This summary consolidates practical approaches and case studies for method modernization and automated method development. It covers strategies for optimizing legacy HPLC assays, migrating to UHPLC, deploying universal detectors, and applying analytical quality by design principles to accelerate method development lifecycles.

Methodology and Instrumentation


Modern laboratories leverage integrated hardware and software ecosystems to streamline liquid chromatography workflows. Key instrumentation and tools include:
  • Thermo Scientific Vanquish UHPLC platforms (Flex, Core, Horizon, Duo)
  • Chromeleon Chromatography Data System with ChromSwordAuto and S-Matrix Fusion QbD software
  • Diode Array Detector FG, Charged Aerosol Detector H, single quadrupole mass spectrometers (ISQ EM, ISQ EC)
  • Automated method scouting kits, solvent extension kits, dual flow-path configurations

Main Results and Discussion


Method Modernization Case Studies
  • Laboratory Instrument Park Upgrade – Replacing legacy HPLC with Vanquish Flex UHPLC reduced instrument-related system suitability failures by 52%, saving an estimated $300 000 annually and increasing uptime six-fold.
  • Simultaneous HPLC and UHPLC Analysis – A Vanquish Flex Duo system ran parallel acetaminophen assays, achieving 2.5× throughput, 50 % sample volume savings, 80 % solvent reduction, and 60 % shorter cycle time.
  • Wide Dynamic Range Detection – The Vanquish DAD FG delivered linear response up to 3700 mAU, enabling single-run quantification of nevirapine and impurities down to 0.012 % relative area.
  • CAD Method Migration – Transitioning acarbose impurity profiling from UV to universal charged aerosol detection on Vanquish HPLC improved stability, sensitivity to nonchromophoric impurities, and MS compatibility using HILIC and Hypercarb columns.

Automated Method Development Examples
  • ChromSwordAuto Connect Workflow – Unattended column and mobile phase scouting, gradient optimization, and robustness testing reduced development time from weeks to hours for stability-indicating esomeprazole assays.
  • Dual-LC Scouting for mRNA Impurities – Vanquish Duo system simultaneously screened ion-exchange and ion-pair reversed-phase conditions, identifying optimal buffers for impurity profiling with minimal manual intervention.
  • Rapid HPLC Method for Multi-Drug Formulation – Automated design of experiments on Triumeq (abacavir, lamivudine, dolutegravir) achieved complete resolution with minimal user input and compliant robustness evaluation.
  • Analytical QbD for Metolazone – S-Matrix Fusion QbD software guided risk assessment, screening, and design space definition, yielding a 54 % shorter run time and statistically verified robustness against pH, temperature, and flow variations.

Benefits and Practical Applications


  • Deep automation reduces manual labor, minimizes human error, and accelerates method rollout for routine and GMP environments.
  • UHPLC platforms enhance sample throughput, conserve solvents and consumables, and support method transfers across laboratories.
  • Universal detectors and MS integration improve peak tracking and enable detection of nonchromophoric analytes and low-level impurities.
  • Analytical quality by design frameworks ensure method robustness, facilitate regulatory compliance, and provide defensible design spaces.

Future Trends and Opportunities for Use


Emerging developments in chromatographic science point to expanded use of machine learning-driven scouting, real-time method adjustment, and deeper integration of LC-MS data. Dual- and multi-flow path systems will support complex biotherapeutic analyses, while universal detection technologies will become standard for comprehensive impurity profiling. Analytical QbD practices will evolve toward full lifecycle management and digital method passports.

Conclusion


Combining modern UHPLC hardware with advanced software tools transforms liquid chromatography method development and routine analysis. Laboratories can achieve significant gains in throughput, cost efficiency, sensitivity, and regulatory compliance by embracing method modernization and automated workflows underpinned by analytical quality by design.

Reference


Thermo Fisher Scientific Method Modernization and Method Development e-Book

Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.

Downloadable PDF for viewing
 

Similar PDF

Toggle
Automated UHPLC method development for mebendazole and related impurities, from method scouting to robustness testing
Application note | 000754 Chromatography Automated UHPLC method development for mebendazole and related impurities, from method scouting to robustness testing Authors Application benefits Soo Hyun Park, Mauro De Pra, Sylvia • The Thermo Scientific™ Vanquish™ UHPLC Method Development system in…
Key words
chromsword, chromswordmethod, methodmebendazole, mebendazolechromeleon, chromeleonconnect, connecthypersil, hypersilvanquish, vanquishgold, golddevelopment, developmentabsorbance, absorbancescientific, scientificoptimization, optimizationaccucore, accucoremau, maudesign
Accelerating method development with Thermo Scientific Vanquish HPLC and UHPLC Method Development Systems
PRODUCT SPOTLIGHT 73997 Accelerating method development with Thermo Scientific Vanquish HPLC and UHPLC Method Development Systems Authors: Alec Valenta1, Carsten Paul1, Peter Zipfell2 Thermo Fisher Scientific, Germering, Germany Thermo Fisher Scientific, Altrincham, UK 1 2 Keywords: HPLC, High Performance Liquid…
Key words
chromeleon, chromeleonmethod, methodchromswordauto, chromswordautodevelopment, developmentvanquish, vanquishscouting, scoutingconnect, connectautorobust, autorobustchromsword, chromswordscout, scouthplc, hplcvault, vaultvalidation, validationscientific, scientificextension
Automated UHPLC method development and robustness test for mebendazole and related impurities
Automated UHPLC method development and robustness test for mebendazole and related impurities Soo Hyun Park1, Mauro De Pra1, Sylvia Grosse1, Carsten Paul1 , Alec Valenta2, Frank Steiner1, 1Thermo Fisher Scientific, Germering, Germany; 2Thermo Fisher Scientific, Pittsburgh, PA, USA ABSTRACT Process…
Key words
scouting, scoutingmethod, methodchromsword, chromswordmebendazole, mebendazolevanquish, vanquishautomated, automateddevelopment, developmentrobustness, robustnessquaternary, quaternarycolumn, columnchromeleon, chromeleonconnect, connectviper, viperorganic, organickit
Development of a stability-indicating method for esomeprazole and related degradation products by automated method scouting and mass detection
APPLICATION NOTE 000460 Development of a stability-indicating method for esomeprazole and related degradation products by automated method scouting and mass detection Authors: Soo Hyun Park, Sylvia Grosse, Mauro De Pra, Michaela Scherz, Frank Steiner Thermo Fisher Scientific, Germering, Germany Keywords:…
Key words
chromsword, chromswordesomeprazole, esomeprazoledegradation, degradationchromeleon, chromeleonconnect, connectreportviewer, reportviewermethod, methoddevelopment, developmentscouting, scoutingbuffer, buffermobile, mobilerename, renamescreening, screeningrelated, relatedphase
Other projects
GCMS
ICPMS
Follow us
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike